«VULNERABLE» ENDOMETRIUM: A MODERN VIEW ON THE PATHOGENESIS AND PATHOGENETIC THERAPY OF ENDOMETRIAL HYPERPLASTIC PROCESSES-Reference-Cited by-同舟云学术

«VULNERABLE» ENDOMETRIUM: A MODERN VIEW ON THE PATHOGENESIS AND PATHOGENETIC THERAPY OF ENDOMETRIAL HYPERPLASTIC PROCESSES

Published:2021-09-20 Issue:3(48) Volume: Page:54-60
ISSN:2303-9949
Container-title:Reproductive Medicine
language:
Short-container-title:RM

Author:

Orazov M.R.,Radzinskiy V.Е.,Khamoshina M.B.,Mullina I.A.,Artemenko Yu.S.

Abstract

Relevance: Endometrium is a unique human tissue with a strong regenerative potential which is implemented after desquamation during each menstrual cycle. At that, regeneration in the endometrium is not accompanied by scarring. Endometrial hyperplasia as a variant of defect transformation is a widespread disease which remains an urgent problem of modern medicine. In recent years, endometrial hyperplasia is becoming more common among patients of reproductive age. This problem is even more significant due to the spread of endometrial cancer in developed countries, and endometrial hyperplasia being its precursor. Purpose: The article describes modern views on the pathogenesis and pathogenetic therapy of endometrial hyperplastic processes. Materials and Methods: Sources available in the Pubmed, Embase, Cochrane databases were analyzed and international reviews of randomized controlled studies in that area were selected for the last few years using the keywords «endometrial hyperplasia,» «atypical hyperplasia,» «endometrial cancer,» «progestins,» and «hysterectomy.» Results: The article discusses the modern ideas about etiopathogenesis and the tactics of management of patients, according to the data of foreign literature. Conclusion: Early diagnostics and timely treatment of endometrial hyperplasiaare an important preventive factor due to the high risk of malignancy. The patient management algorithm depends on many factors: the type of hyperplastic conditions, the patient’s age, unrealized reproductive function, and etc. Progestin therapy is more preferable for young patients wishing to preserve reproductive function. If cellular atypia is present, panhysterectomy is the first line of treatment for women who have realized their reproductive function and have endometrial hyperplasia with atypia.

Publisher

MedMedia Kazakhstan

Reference34 articles.

1. Оразов М.Р. Акушерство и гинекология: новости, мнения, обучение, 2016; 3: 46-58 [Orazov M.R. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie, 2016; 3: 46-58];

2. Оразов М.Р., Радзинский В.Е., Аракелов С.Э., Хамошина М.Б., Носенко Е.Н., Духин А.О., Токтар Л.Р., Читанава Ю.С., Орехов Р.Е., Абитова М.З. Трудный пациент, 2019; 17(5): 19-21 [Orazov M.R., Radzinskij V.E., Arakelov S.E’., Xamoshina M.B., Nosenko E.N., Duxin A.O., Toktar L.R., Chitanava Yu.S., Orexov R.E., Abitova M.Z. Trudnyj pacient, 2019; 17(5): 19-21];

3. Siegel R.L., Miller K.D., Jemal A. CA Cancer J Clin., 2018; 68(1): 7-30. https://doi.org/10.3322/caac.21442;

4. Каприн А.Д., Старинский В.В., Шахзодова А.О. Злокачественные новообразования в России в 2019 году (заболе- ваемость и смертность). – МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. − илл. − 252 с. [Kaprin A.D., Starinskij V.V., Shaxzodova A.O. Zlokachestvennye novoobrazovaniya v Rossii v 2019 godu (zabolevaemost’ i smertnost’). – MNIOI im. P.A. Gercena − filial FGBU «NMIC radiologii» Minzdrava Rossii, 2020. − ill. − 252 s.];

5. Iversen M.L., Dueholm M. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 222: 171-175. https://doi.org/10.1016/j.ejogrb.2018.01.026;